Bg pattern

MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: Information for the user

Minims Prednisolone 5 mg/ml eye drops in single-dose container

sodium prednisolone phosphate

Read this leaflet carefully before starting to use this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms, as it may harm them.
  • If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What Minims Prednisolone is and what it is used for
  2. What you need to know before using Minims Prednisolone
  3. How to use Minims Prednisolone
  4. Possible side effects
  5. Storage of Minims Prednisolone
  6. Contents of the pack and further information

1. What Minims Prednisolone is and what it is used for

Minims Prednisolone contains sodium prednisolone phosphate, which belongs to a group of medicines called corticosteroids. It is used to treat eye inflammation (redness and pain in the eyes) when it is not caused by an infection. The affected part of the eye varies depending on the cause of the inflammation.

This medicine is indicated for adults.

Minims Prednisolone is not suitable for the treatment of eye infections.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Minims Prednisolone

Do not use Minims Prednisolone:

  • if you are allergic to prednisolone or any of the other components of this medicine (listed in section 6).
  • if you have an eye infection caused by a virus, fungus, or bacteria.

Warnings and precautions

Consult your doctor or pharmacist if you notice blurred vision or visual disturbances.

You should not wear contact lenses when using this medicine, as its use may increase the risk of infection.

Prolonged use may cause an increase in pressure inside the eye. You should not use this medicine if you are at risk of developing glaucoma.

Children and adolescents

This medicine should not be used in children and adolescents.

Other medicines and Minims Prednisolone

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, including those obtained without a prescription.

Minims Prednisolone may increase the effects of:

  • medicines used to treat epilepsy (barbiturates)
  • medicines used to help you sleep or relieve anxiety (sedative hypnotics)
  • medicines used to treat depression (tricyclic antidepressants)

Minims Prednisolone may decrease the effects of:

  • medicines such as anticholinesterases (used to reduce intestinal movement and for myasthenia gravis, a disease that weakens the muscles).
  • medicines used to treat viral eye infections.
  • medicines similar to aspirin, called salicylates (used for inflammation, pain, fever, and to prevent excessive blood clotting).

Other medicines may increase the effects of Minims Prednisolone, and your doctor may want to monitor you closely if you are taking them (including some HIV medicines, such as cobicistat).

If used in combination with other ophthalmic preparations, an interval of at least 5 minutes should be left between successive applications. Ophthalmic gels and ointments should always be administered last.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

Driving and using machines

You may notice blurred vision for a short period immediately after applying Minims prednisolone. If this occurs, wait until your vision is clear before driving or using machinery.

Excipients

This medicine contains 0.07 mg of phosphates in each drop, which is equivalent to 0.91 mg/0.5 ml.

If you have severe damage to the transparent layer of the front of the eye (cornea), phosphates may cause (in very rare cases) opaque spots on the cornea due to calcium deposits during treatment.

3. How to use Minims Prednisolone

Follow the instructions for using this medicine exactly as stated in this leaflet or as directed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.

Remember:Minims Prednisoloneshould only be applied to the eyes. The drops are for single use and are provided in single-dose units containing 13.5 drops, which are sufficient to treat both eyes if necessary. Once opened, use immediately. Discard any unused portion.

The recommended dose is:

One drop in one or both eyes with the frequency indicated by your doctor. It is usually administered one drop 4 times a day for 1 to 3 weeks and then one drop twice a day. In more severe cases, your doctor may indicate that you start with one drop 8 times a day during the first week.

Method of administration (application of Minims Prednisoloneeye drops)

If you are going to put the eye drops in yourself, follow these instructions carefully. To facilitate the correct application of the eye drops, it may be helpful to sit in front of a mirror so that you can see what you are doing.

  1. Wash your hands.
  2. Gently clean the area around your eyes with a cloth to remove any moisture.
  3. Open the single-dose container (image 1).

Medicine bottle with connected needle showing curved arrows indicating rotation and downward arrow for insertion

Image 1

  1. Gently pull the lower eyelid down (image 2).

Stylized human eye with long eyelashes and thick outline showing pupil and lower eyelid

Image 2

  1. Carefully place one drop inside the middle area of the lower eyelid. Be careful not to touch your eye with the container (image 3).

Woodpecker in profile with long thin beak perched on a thin branch

Image 3

  1. Release the lower eyelid and gently press the inner corner of the eye against the bridge of the nose for 1 or 2 minutes. While your finger presses the nose, blink slowly a few times to spread the drop across the entire surface of the eye (image 4).

Open eye showing eyelashes and upper and lower eyelid with light reflection on the cornea

Image 4

  1. Wipe away any excess medicine with a cloth.
  2. Repeat these steps in the other eye if necessary; then discard the container, even if some solution remains.

If you use more Minims Prednisolone than you should:

If you administer too much Minims Prednisolone to your eye, you are unlikely to have any problems. If you have any doubts, consult your doctor. If you accidentally ingest Minims Prednisolone or feel unwell after using this medicine, contact your doctor or go to the nearest hospital emergency department immediately.

In case of overdose or accidental ingestion, contact your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Minims Prednisolone

Use the eye drops as soon as you remember and apply the next dose at the usual time. Do not administer a double dose to make up for the missed dose.

If you stop using Minims Prednisolone

If you have any further questions about using this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Very common side effects (may affect up to 1 in 10 people):

Increased eye pressure.

Very rare side effects (may affect up to 1 in 10,000 people):

Corneal calcification has been reported in patients with significantly damaged corneas.

Side effects of unknown frequency

Blurred vision.

Prolonged and frequent use of corticosteroids may cause clouding of the lens (cataract formation).

Secondary glaucoma, a disease that can damage the optic nerve and cause vision loss, may occur as a result of increased eye pressure.

Consult your doctor if you notice any change in your vision.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es/.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Minims Prednisolone

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the carton and on the pouch of the container, after "EXP".

Use the single-dose container once and discard any remaining solution.

Store below 25°C. Do not refrigerate or freeze. Keep in the original packaging and keep the blister pack in the outer packaging, as the product is very sensitive to light.

Medicines should not be disposed of via wastewater or household waste. Place the containers and medicines you no longer need in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of Minims Prednisolone

  • The active ingredient is sodium prednisolone phosphate
  • The other ingredients are: disodium edetate, sodium dihydrogen phosphate dihydrate, sodium chloride, sodium hydroxide (to adjust the pH), purified water

Appearance of the product and contents of the container

Minims Prednisolone is presented in a 0.5 ml polypropylene container, conical in shape, with a screw cap. Each single-dose container is wrapped in an individual polypropylene/paper pouch.

Each box contains 20 single-dose containers.

Marketing authorization holder and manufacturer

Marketing authorization holder

BAUSCH + LOMB IRELAND LIMITED

3013 Lake Drive

Citywest Business Campus

Dublin 24, D24PPT3

Ireland

Manufacturer

Laboratoire Chauvin

Zone Industrielle de Ripotier

50 Avenue Jean Monnet

07200 Aubenas

France

You can request more information about this medicine by contacting the local representative of the marketing authorization holder.

Local representative in Spain

Bausch & Lomb S.A.

Avda. Valdelaparra, nº4

28108 Alcobendas, Madrid

Phone: 91 – 657 63 00

This leaflet was last revised in September 2023.

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/

Online doctors for MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
The active ingredient in MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is prednisolone. This information helps identify medicines with the same composition but different brand names.
Who manufactures MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Bausch + Lomb Ireland Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MINIMS PREDNISOLONE 5 MG/ML EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (prednisolone) include PRED FORTE 10 mg/ml EYE DROPS IN SUSPENSION, AMEXXINE 1 mg/ml EYE DROPS SOLUTION, COLIRCUSI DEXAMETHASONE 1 mg/ml eye drops solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media